Riskpilot← Back to searchSign inGet full accessBIOSENSE LABORATORIES AS
ASActiveOrg 976228251Thormøhlens Gate 53A, 5006 BergenTechnical testing and analysis · NACE 7120Est. 19963 employees
Revenue 2025
NOK 4,2M
-1% vs 2024
EBITDA margin
-29.4%
-2296% vs 2024
Equity ratio
88.6%
Financial strength
Net profit 2025
NOK -1,4M
-832% vs 2024
| Revenue | NOK 4,2M | -1% |
| EBITDA | NOK -1,2M | -2296% |
| Net profit | NOK -1,4M | -832% |
| Total assets | NOK 5,5M | +13% |
| Equity | NOK 4,9M | +17% |
| Employees | 3 | — |
Legal name
BIOSENSE LABORATORIES AS
Org number
976228251
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
21. februar 1996
Share capital
NOK 1 460 440
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Utøvelse av tjenester, design, konstruksjon, produksjon, produksjonsoppfølging og aktiviteter i forbindelse med industriell og kommersiell virksomhet innen bioteknologi, drive handel, import og eksport, samt delta i andre selskaper og alt hva hermed står i forbindelse. Selskapet kan også utvikle seg i andre områder som faller naturlig inn i forretningskonseptet.
Address
Thormøhlens Gate 53A, 5006 Bergen
Phone
+4755543966
Email
biosense@biosense.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 200 | 0 | 0 | 3 600 | 4 022 | 3 363 | 3 067 | 3 397 | 4 131 | 6 045 | 7 148 | 4 963 | 3 741 | 4 231 | 4 203 |
| Staff expenses | −1 677 | −0 | −0 | −1 318 | −1 511 | −1 289 | −1 127 | −1 079 | −1 446 | −2 090 | −2 706 | −2 764 | −2 480 | −1 943 | −2 667 |
| EBITDA | 36 | 0 | 0 | 24 | 167 | −257 | 97 | 275 | 501 | 1 012 | 1 439 | −414 | −793 | −51 | −1 234 |
| Depreciation & amort. | −503 | −0 | −0 | −32 | −25 | −14 | −0 | −0 | −3 | −14 | −65 | −168 | −161 | −160 | −210 |
| EBIT | −467 | 0 | 0 | −8 | 142 | −271 | 97 | 275 | 498 | 998 | 1 374 | −582 | −954 | −212 | −1 444 |
| Net financials | −80 | 0 | 0 | 26 | 53 | −31 | 30 | −13 | 2 | 50 | −20 | 96 | 50 | 61 | 34 |
| Profit before tax | −548 | 0 | 0 | 19 | 194 | −303 | 127 | 263 | 499 | 1 048 | 1 355 | −487 | −904 | −151 | −1 410 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −548 | 0 | 0 | 19 | 194 | −303 | 127 | 263 | 499 | 1 048 | 1 355 | −487 | −904 | −151 | −1 410 |
| Item | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 619 | — | — | 1 353 | 1 997 | 1 672 | 1 499 | 1 742 | 2 457 | 3 821 | 5 314 | 4 058 | 3 021 | 4 861 | 5 504 |
| Equity | 1 888 | — | — | 740 | 934 | 632 | 759 | 1 021 | 1 521 | 2 569 | 3 923 | 3 437 | 2 533 | 4 184 | 4 876 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 731 | 0 | 0 | 613 | 1 063 | 1 041 | 740 | 721 | 936 | 1 252 | 1 391 | 622 | 488 | 678 | 628 |
| Total debt | 731 | 0 | 0 | 613 | 1 063 | 1 041 | 740 | 721 | 936 | 1 252 | 1 391 | 622 | 488 | 678 | 628 |
EBITDA margin
-29.4%
This company
15.8%
Market median
-286% vs market
20102025
Equity ratio
88.6%
This company
38.2%
Market median
+132% vs market
20102025
Return on equity
-28.9%
This company
18.4%
Market median
-257% vs market
20102025
Net profit margin
-33.5%
This company
8.1%
Market median
-514% vs market
20102025
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20102025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20102025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FF Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 18.8% | 18.8% | 2023 | |
| Individual | 18.8% | 18.8% | 2023 | |
| Individual | 7.8% | 7.8% | 2023 | |
| Individual | 2.0% | 2.0% | 2022 | |
Cayman Chemical Company Inc. | Company | 2.0% | 2.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOSENSE LABORATORIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frank Fleissig Mikkelsen | Chief Executive Officer | 0 companies |
| Anders Goksøyr | Board of Directors | 0 companies |
| Olaf Magnus Strøm Haavik | Chairman | 0 companies |